Evidence map›Paper›PMID 36527791›Full record

ArticleDifferentiation; research in biological diversity

Fgf8 promotes survival of nephron progenitors by regulating BAX/BAK-mediated apoptosis.

Matthew J Anderson, Salvia Misaghian, Nirmala Sharma, Alan O Perantoni, Mark Lewandoski

Open access · hybridAbstract read
In one paragraph

Article in Differentiation; research in biological diversity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Matthew J AndersonGenetics of Vertebrate Development Section, Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.
Salvia MisaghianGenetics of Vertebrate Development Section, Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.
Nirmala SharmaRenal Differentiation and Neoplasia Section, Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.
Alan O PerantoniRenal Differentiation and Neoplasia Section, Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA.
Mark LewandoskiGenetics of Vertebrate Development Section, Cancer and Developmental Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA. Electronic address: lewandom@nih.gov.
National Institutes of Health · US

Funding

The Role of Fgf Signaling in Vertebrate DevelopmentZIABC010338 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEWANDOSKI, MARK B · 2009 to 2025
$8.8M
Identification and characterization of FGF target genesZIABC011321 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEWANDOSKI, MARK B · 2010 to 2025
$4.6M
Intramural NIH HHS ZIA BC010338
6 · The paper itself

Abstract

Fibroblast growth factors (Fgfs) have long been implicated in processes critical to embryonic development, such as cell survival, migration, and differentiation. Several mouse models of organ development ascribe a prosurvival requirement specifically to FGF8. Here, we explore the potential role of prosurvival FGF8 signaling in kidney development. We have previously demonstrated that conditional deletion of Fgf8 in the mesodermal progenitors that give rise to the kidney leads to renal aplasia in the mutant neonate. Deleterious consequences caused by loss of FGF8 begin to manifest by E14.5 when massive aberrant cell death occurs in the cortical nephrogenic zone in the rudimentary kidney as well as in the renal vesicles that give rise to the nephrons. To rescue cell death in the Fgf8 mutant kidney, we inactivate the genes encoding the pro-apoptotic factors BAK and BAX. In a wild-type background, the loss of Bak and Bax abrogates normal cell death and has minimal effect on renal development. However, in Fgf8 mutants, the combined loss of Bak and Bax rescues aberrant cell death in the kidneys and restores some measure of kidney development: 1) the nephron progenitor population is greatly increased; 2) some glomeruli form, which are rarely observed in Fgf8 mutants; and 3) kidney size is rescued by about 50% at E18.5. The development of functional nephrons, however, is not rescued. Thus, FGF8 signaling is required for nephron progenitor survival by regulating BAK/BAX and for subsequent steps involving, as yet, undefined roles in kidney development.

Indexed as

KidneyNephronsAnimalsApoptosisbcl-2-Associated X ProteinCell DifferentiationFemaleFibroblast Growth Factor 8Fibroblast Growth FactorsMicePregnancybcl-2-Associated X ProteinFgf8 protein, mouseFibroblast Growth Factor 8Fibroblast Growth FactorsApoptosisCell deathFgf8Fibroblast growth factorKidney

Identifiers

PMID36527791
PMCPMC10718080
OpenAlexW4311760596

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.